Breaking News

OctoPlus, The Medicines Co. Sign Development Contract

OctoPlus N.V. has signed a development and manufacturing contract with U.S.-based The Medicines Company.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

OctoPlus N.V. has signed a development and manufacturing contract with U.S.-based The Medicines Company. Under the contract terms, OctoPlus will perform process development and clinical manufacturing for The Medicines Co. related to MDCO-216 (ApoA-I Milano/phospholipid complex). OctoPlus provides formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. OctoPlus also offers drug delivery technologies for the development of controll...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters